Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Most Advanced Countries in Medicine

In this article, we take a look at the 15 most advanced countries in medicine. You can skip our detailed analysis of the healthcare industry and go directly to 5 Most Advanced Countries in Medicine

The recent pandemic was the best reflection of the advancements in the field of medicine. Vaccines were developed at a lightning-fast pace, with the first vaccine for Covid-19 approved for Emergency Use Authorization (EUA) only a year after the outbreak. 

It was developed by a joint effort of two of the most advanced pharmaceutical companies when it comes to R&D – Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX). The former is an American company while the latter is German.

Other top pharma companies include names like Cigna Corporation (NYSE:CI), Sanofi (NASDAQ:SNY), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ:AMGN).

Due to the medicine industry’s role in the improvement of human well-being, it leads to GDP growth through labor productivity and personal spending. The correlation coefficients for this are demonstrable.  

The US, Switzerland and Norway are some of the most advanced countries when it comes to the field of medicine, with huge healthcare spending, numerous pharmaceutical companies and sophisticated academia.

Outlook

Medicine is one of the fastest growing fields in the world. It encompasses the pharmaceutical industry, medical schools and hospitals. The demand for healthcare is expected to increase due to a variety of factors, such as an aging population and advances in medical technology. 

According to the Pharma Outlook 2030 by KPMG, many trends are shaping the pharma industry for 2030. For instance, the free-for-service payment model is increasingly being challenged by the end-users, hospitals and insurance agencies. They want the pricing model to be designed around the success and the quality of the product. 

One of the most prominent results of this is Cigna Corporation (NYSE:CI)’s 2016 value-based contracts with Sanofi (NASDAQ:SNY), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ:AMGN) for cholesterol drugs, with the insurance agencies receiving discounts if their therapies do not reduce cholesterol levels enough. 

Advances in big data and machine learning are also likely to allow for the pre-emptive measures against the onset of diseases instead of just treating them. Further, machine learning is also set to play a pivotal role in drug discovery.

A recent example is the AlphaFold, a deep learning model by Alphabet Inc. (NASDAQ:GOOG)’s subsidiary – DeepMind. It has solved 98.5% of human proteins’ structures, an important leap in drug discovery. Priorly, it had been a challenge that had puzzled molecular biologists for half a century. 

Major advances are primarily happening on the academic front of medicine, and AI in the field is pervasive. For instance, Harvard University researchers have come up with an automated cancer detection system, which uses AI to find breast cancer by examining lymph node cells. 

Given the trends, AI is largely going to be an integral field to medicine. Another field that is likely to augment the pharma industry by 2030 is nanotechnology. In this regard, Novartis, in partnership with Proteus, has developed a smart pill that can be swallowed for diagnostics purposes. 

The pharmaceutical manufacturing market is one of the fastest growing in the world. It was worth $358 billion in 2020 and is expected to reach a valuation of $1.2 trillion by 2030, growing at a solid CAGR of 13%, as reported by Precedence Research.

On the other hand, the drug-discovery industry was valued at $75 billion in 2021, and is projected to grow with a CAGR of 9%, to $162 billion in 2030.

Lastly, the hospital industry is projected to be valued at $2 trillion by 2028, after a growth with a CAGR of 12.5% during the forecast period of 2021-2028. It was valued at $820 billion in 2021.

Let’s now move to the 15 most advanced countries in medicine. 

Our Methodology 

For our list of the most advanced nations in medicine, we’ve ranked them based on three reports. These are the following – Legatum Prosperity Index, 2021, Countries’ Citations in Clinical Medicine, by Institute of Scientific Information, and a Health Care Index

Legatum Prosperity Index’s health ‘pillar’ measures the extent to which people have access to essential and advanced healthcare services. The Institute of Scientific Information report, on the other hand, is about the number of citations per paper for countries in the field of clinical medicine. 

Lastly, the CEO-World report is based on a statistical analysis that accounted for factors such as healthcare infrastructure, government readiness, healthcare professionals and quality of medicine among others. 

We’ve averaged out the rankings for the top countries in the three reports. We haven’t considered the countries that did not appear in more than one report. The data for healthcare spending and physicians per 1,000 people in our listed countries comes from the World Bank.

Here are the 15 most advanced countries in medicine:

15. United States

Health Care Index: 45.62

Citations Per Paper: 13.50

Legatum-Prosperity Health Score: 221.85

The United States is the biggest economy, as well as the most technologically advanced country in the world. When it comes to the academic field of clinical medicine, it is the number one country in terms of average number of citations per paper. 

Its Harvard Medical School, Stanford University and John Hopkins University are some of the top institutes engaged in cutting-edge research, including, in the medicinal field. 

On the corporate front, the US is home to some of the most advanced pharma corporations in the world. These include Pfizer Inc. (NYSE:PFE), Cigna Corporation (NYSE:CI), Amgen Inc. (NASDAQ:AMGN) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). The country’s top hospital companies include HCA Healthcare and Tenet Healthcare Corporation. In 2019, the US spent 17% of its GDP on healthcare.

14. Austria

Health Care Index: 71.32

Citations Per Paper: 8.39

Legatum-Prosperity Health Score: 238.94

Austria is above average in the EU when it comes to advancement in medicine. It has 5 doctors per 1,000 people and its healthcare spending as a share of its GDP was 10.43% in 2019.

13. France

Health Care Index: 65.38

Citations Per Paper: 8.64

Legatum-Prosperity Health Score: 241.49

France is one of the most prominent countries in Europe. The country has a robust healthcare infrastructure in place for its citizens. In the year 2019, France spent 11.06% of its GDP in healthcare, including medical research & development.

12. Australia

Health Care Index: 67.99

Citations Per Paper: 9.85

Legatum-Prosperity Health Score: 240.56

Australia is one of the most advanced countries in medicine and healthcare. In 2019, the country spent 9.91% of its GDP on healthcare. It is home to some of the biggest hospital companies including Sonic Healthcare Limited and Ramsay Healthcare Limited. Australia’s Translational Research Institute is among the top medical research institutes in the world.

11. Belgium

Health Care Index: 64.63

Citations Per Paper: 11.56

Legatum-Prosperity Health Score: 241.72

Belgium is located in Northwestern Europe. It spent 10.66% of its GDP in 2019 on the healthcare sector. In the same year, there were six doctors available in the country for every 1,000 Belgian citizens. 

Belgium’s corporate health-sector comprises companies like Janssen Pharmaceuticals, which is headquartered in Beerse, and owned by Johnson & Johnson. With regard to R&D in medicine, its universities like Ghent University and Catholic University of Leuven stand out.

10. Sweden

Health Care Index: 46.24

Citations Per Paper: 11.78

Legatum-Prosperity Health Score: 246.23

Sweden is located in the Scandinavian region of Europe. The share of healthcare spending as a percentage of Sweden’s GDP was 10.87% in 2019. There are four doctors for every 1,000 citizens in the country. Its top research institutes in medicine include Karolinska Institute and Uppsala University. On the corporate end, the country has such companies as AstraZeneca.

9. Israel

Health Care Index: 50.15

Citations Per Paper: 8.14

Legatum-Prosperity Health Score: 248.53

Israel is one of the most advanced countries in medicine. The percentage of healthcare spending in its 2019 GDP was 7.46%, and the country had six doctors for every 1,000 of its citizens. 

Its Tel Aviv University and Weizmann Institute of Science are two of the top research universities in the country for medicine. Israel leads research and development in the field of bioconvergence.

8. Switzerland

Health Care Index: 52.25

Citations Per Paper: 11.51

Legatum-Prosperity Health Score: 244.48

Switzerland is one of the most advanced countries in medicine in Europe. Its University of Bern and University of Zurich are two of the institutes at the frontier when it comes to medical research and schooling. The country is also home to Novartis, one of the leading pharma corporations in the world.

7. Finland

Health Care Index: 59.6

Citations Per Paper: 12.62

Legatum-Prosperity Health Score: 244.23

Finland is another Scandinavian country on the list of most advanced countries in medicine. Its University of Helsinki and University of Turku are the two leading institutes for research & development, including in the field of medicine. In 2019, the country spent 9.15% of its GDP on the healthcare sector.

Apart from Finnish pharma companies, the country also hosts foreign corporations like Pfizer Inc. (NYSE:PFE), Cigna Corporation (NYSE:CI), Amgen Inc. (NASDAQ:AMGN) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN).

6. Taiwan

Health Care Index: 77.7

Citations Per Paper: 5.28

Legatum-Prosperity Health Score: 250.28

Taiwan is located in Southeast Asia. It has highly sophisticated healthcare infrastructure, owing to its early adoption of modern technologies. Some of its top medical institutes include Taipei Medical University and Kaohsiung Medical University. 

Click to continue reading and see the 5 Most Advanced Countries in Medicine.

Suggested Articles:

Disclosure: none. 15 Most Advanced Countries in Medicine is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!